Africa CDC, WHO Welcome U.S. Support for Vaccine-Patent Waiver
(Bloomberg) -- The African Union welcomed U.S. backing for a proposal to waive patent protections on Covid-19 vaccines and urged other countries to back the idea.
The Biden administration's decision is “a remarkable expression of leadership,” Africa Centres for Disease Control & Prevention Director John Nkengasong said in an online briefing Thursday. “My message is an appeal to the international community, to our partners, to please be on the right side of history because history will remember this.”
By supporting the proposal, the U.S. joined an effort to increase global supply and access to the life-saving shots as the gap between rich and poor nations widens. The European Union and China have indicated a willingness to take part in the debate about the waiver, which needs to be agreed upon at the World Trade Organization.
READ: U.S. Vaccine Patent Shock Roils Pharma as Talks Move to WTO (2)
The possibility of making Covid-19 vaccines in Africa is “a very important part of the solution,” the World Health Organization's regional director for Africa, Matshidiso Moeti, said in a separate briefing. However, “there are other things needed to expand and quickly diversify production” such as readily available ingredients, suitable manufacturers and adequate regulation, she said.
Production on the continent would avert vaccine inequality, which is growing, with the U.S. and many European countries expanding their campaigns to younger age groups, while many African countries struggle to vaccinate vulnerable groups, Moeti said.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.